Register | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This promotional virtual conference has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed at these meetings, and prescribing information will be available during the conference. Lilly is a registered trademark of Eli Lilly and Company.© 2021 Eli Lilly and Company. All rights reserved.

Prescribing information for Lilly products can be accessed at the following links: Abasaglar® (insulin glargine)Humalog® (insulin glargine)Lyumjev® (insulin lispro) (Please note: Lyumjev is not available in the ROI), Trulicity® (dulaglutide). For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only).

21st Annual Abracadabra Diabetes Nursing Conference

Please note you will be registering for all three meeting dates

This promotional virtual conference has been developed, organised and funded by Lilly in conjunction with the Abracadabra Programme Planning Committee. Lilly Products will be discussed at these meetings, and prescribing information will be available during the conference. Lilly is a registered trademark of Eli Lilly and Company.© 2021 Eli Lilly and Company. All rights reserved.​

Prescribing information for Lilly products can be accessed at the following links: Abasaglar® (insulin glargine)Humalog® (insulin glargine)Lyumjev® (insulin lispro) (Please note: Lyumjev is not available in the ROI), Trulicity® (dulaglutide). For more information about Lilly products please visit www.lillydiabetes.co.uk (UK only).

Adverse events and product complaints should be reported. Reporting forms and further information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store (UK) or www.hpra.ie (ROI). Adverse events and product complaints should also be reported to Lilly: please call Lilly UK on +44 (0) 1256 315000 or Lilly Ireland on +353 (0)1 664 0446 (ROI).

PP-LD-GB-1047 | March 2021

Thank you for registering.

We look forward to welcoming you online. You will receive a confirmation email shortly and we will send you a reminder email closer to the start of the broadcast.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.